Return to Library
Colitis Visual Overview
Topic

Colitis

💡 What You Need to Know

  • Definition: Microscopic colitis is an inflammatory condition of the colon characterized by chronic watery diarrhea, normal appearance of the colon lining during colonoscopy, but distinct microscopic changes in biopsy samples.
  • Types: Primarily categorized into Collagenous Colitis (thickened subepithelial collagen layer) and Lymphocytic Colitis (increased intraepithelial lymphocytes).
  • Prevalence: More common in older adults, particularly women, but can affect any age group.
  • Etiology: The exact cause is unknown, but it is thought to involve an abnormal immune response to luminal factors, genetic predisposition, and association with certain medications (e.g., NSAIDs, PPIs, SSRIs).

🤒 Associated Symptoms

  • Chronic Watery Diarrhea: The hallmark symptom, often severe and non-bloody, persisting for weeks or months.
  • Abdominal Pain: Cramping or discomfort in the abdomen, which can vary in intensity.
  • Fecal Incontinence: Difficulty controlling bowel movements due to the urgency and watery nature of diarrhea.
  • Weight Loss: Unintentional weight loss can occur due to malabsorption or reduced food intake secondary to symptoms.
  • Fatigue: Generalized tiredness and lack of energy, often associated with chronic illness and dehydration.
  • Dehydration: Symptoms like dry mouth, increased thirst, and reduced urine output due to significant fluid loss.

🛡 Crucial Precautions

  • Medication Review: Discuss all current medications with your physician, as some drugs (e.g., NSAIDs, proton pump inhibitors) can exacerbate or induce microscopic colitis.
  • Hydration Management: Maintain adequate fluid and electrolyte intake, especially during acute diarrheal episodes, to prevent dehydration.
  • Symptom Monitoring: Keep a detailed record of bowel movements, stool consistency, and any associated symptoms to help guide treatment adjustments.
  • Avoidance of Triggers: Identify and avoid potential dietary triggers or substances that worsen symptoms, which can be highly individual.
  • Adherence to Treatment: Strictly follow prescribed medication regimens (e.g., budesonide, loperamide) and lifestyle modifications to manage inflammation and symptoms.

🍽 Dietary Directions & Restrictions

  • Hydration Focus: Prioritize clear fluids, electrolyte-rich beverages, and water to counteract fluid loss from diarrhea.
  • Small, Frequent Meals: Opt for smaller, more frequent meals rather than large ones to reduce the burden on the digestive system.
  • Potential Trigger Foods: Consider temporarily limiting common irritants such as caffeine, alcohol, artificial sweeteners, and high-fat foods.
  • Fiber Management: While fiber is generally healthy, some individuals may find high-fiber foods exacerbate symptoms during flares; a low-residue diet might be beneficial temporarily.
  • Lactose/Gluten Intolerance: Evaluate for potential lactose or gluten intolerance, as these can sometimes co-exist or mimic symptoms; a trial elimination may be considered under medical guidance.
  • Low FODMAP Diet: Some patients report improvement with a low FODMAP diet, which restricts certain fermentable carbohydrates, but this should be implemented with professional dietary advice.

⚠️ Attendant Guidelines

  • Seek Medical Attention: Promptly report any signs of severe dehydration (e.g., dizziness, confusion, decreased urination), persistent high fever, or severe abdominal pain.
  • Medication Side Effects: Be aware of potential side effects of prescribed medications, such as budesonide (e.g., mood changes, insomnia) or anti-diarrheals (e.g., constipation, abdominal discomfort).
  • Electrolyte Imbalance: Monitor for symptoms of electrolyte imbalance, such as muscle weakness, cramps, or irregular heartbeats, especially with prolonged diarrhea.
  • Nutritional Deficiencies: Discuss with your healthcare provider about potential vitamin and mineral deficiencies that may arise from chronic diarrhea and malabsorption.
  • Follow-up Appointments: Adhere to all scheduled follow-up appointments to monitor disease activity, treatment effectiveness, and adjust management plans as needed.

🩺 Physician's Perspective

  • Diagnostic Confirmation: Diagnosis relies on colonoscopy with biopsies, as the colon appears normal macroscopically, but microscopic examination reveals characteristic inflammatory changes.
  • First-Line Treatment: Oral budesonide is often the first-line therapy due to its topical action and low systemic bioavailability, effectively inducing remission in many patients.
  • Symptomatic Management: Anti-diarrheal medications like loperamide can provide symptomatic relief, especially during initial treatment phases or for mild cases.
  • Addressing Underlying Causes: Identifying and discontinuing potential drug triggers (e.g., NSAIDs, PPIs) is crucial for effective management.
  • Long-Term Management: While often a chronic condition, microscopic colitis typically has a benign course. Relapses are common, requiring intermittent or long-term low-dose therapy.

🎓 Academic & Nursing Corner

  • Patient Education: Educate patients on the chronic nature of microscopic colitis, the importance of medication adherence, and dietary modifications.
  • Fluid and Electrolyte Balance: Monitor patients for signs of dehydration and electrolyte imbalances, providing oral rehydration solutions or intravenous fluids as necessary.
  • Medication Administration: Instruct patients on the correct administration of budesonide (e.g., usually once daily in the morning) and potential side effects.
  • Stool Assessment: Document stool frequency, consistency (using Bristol Stool Chart), and presence of any blood or mucus.
  • Nutritional Support: Collaborate with dietitians to provide personalized dietary advice, focusing on symptom management and preventing nutritional deficiencies.
  • Psychosocial Support: Acknowledge the impact of chronic diarrhea on quality of life and provide resources for coping strategies and support groups.

🔬 Clinical Reference Index

  • ICD-10 Codes: K52.831 (Collagenous colitis), K52.832 (Lymphocytic colitis), K52.838 (Other microscopic colitis), K52.839 (Microscopic colitis, unspecified).
  • Histopathological Features: Collagenous colitis: thickened subepithelial collagen band (>10 µm), increased intraepithelial lymphocytes. Lymphocytic colitis: increased intraepithelial lymphocytes (>20 per 100 epithelial cells) with normal collagen band.
  • Differential Diagnosis: Irritable Bowel Syndrome (IBS-D), Celiac Disease, Inflammatory Bowel Disease (Crohn's, Ulcerative Colitis), Bile Acid Malabsorption, Infectious Colitis.
  • Treatment Guidelines: American College of Gastroenterology (ACG) guidelines for the management of microscopic colitis.
  • Pharmacological Agents: Budesonide (controlled-release), Loperamide, Bismuth subsalicylate, Cholestyramine (for bile acid malabsorption), Immunomodulators (e.g., azathioprine, methotrexate) in refractory cases.
  • Diagnostic Modality: Colonoscopy with random biopsies from multiple segments of the colon (right, transverse, left, sigmoid, rectum) is essential for diagnosis.